Internal Reference Number: FOI_9524
Date Request Received: 07/07/2026 00:00:00
Date Request Replied To: 21/07/2026 00:00:00
This response was sent via: By Email
Request Summary: Oncology Gastro Cancer
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 3 months with any systemic anti-cancer therapies for Gastric cancer or cancer of the Gastro-Oesophageal Junction? | |
| Answer To Question 1: 26 | |
| Question Number 2: How many patients were treated in the past 3 months for gastric cancer (any stage) with: • CAPOX (Capecitabine with Oxaliplatin) • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) • Lonsurf (Trifluridine - tipiracil) • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Zolbetuximab (Vyloy) • Any other systemic anti-cancer therapy • Palliative care only • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) • Taxanes (e.g. docetaxel, paclitaxel) • Irinotecan Chemotherapy | |
| Answer To Question 2: How many patients were treated in the past 3 months for gastric cancer (any stage) with: • CAPOX (Capecitabine with Oxaliplatin)less than 5 • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) less than 5 • Lonsurf (Trifluridine - tipiracil) less than 5 • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) 0 • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) less than 5 • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) 0 • Zolbetuximab (Vyloy)0 • Any other systemic anti-cancer therapy less than 5 • Palliative care only less than 5 • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) 0 • Taxanes (e.g. docetaxel, paclitaxel) 0 • Irinotecan Chemotherapy 0 | |
| Question Number 3: How many patients were treated in the past 3 months for cancer of the gastro-oesophageal junction (any stage) with: • CAPOX (Capecitabine with Oxaliplatin) • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) • Lonsurf (Trifluridine - tipiracil) • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Zolbetuximab (Vyloy) • Any other systemic anti-cancer therapy • Palliative care only • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) • Taxanes (e.g. docetaxel, paclitaxel) • Irinotecan Chemotherapy | |
| Answer To Question 3: • CAPOX (Capecitabine with Oxaliplatin)less than 5 • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin)less than 5 • Lonsurf (Trifluridine - tipiracil)less than 5 • Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)0 • Pembrolizumab (any formulation) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)7 • Pembrolizumab (395 mg or 790mg solution for injection only) in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)less than 5 • Zolbetuximab (Vyloy) 0 • Any other systemic anti-cancer therapy 10 • Palliative care only less than 5 • Trastuzumab in combination with cisplatin and capecitabine (or 5-fluorouracil) 0 • Taxanes (e.g. docetaxel, paclitaxel)0 • Irinotecan Chemotherapy less than 5 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
